메뉴 건너뛰기
Diabetes Care
Volumn 41, Issue 4, 2018, Pages e47-e49
SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis: A South Australian clinical case series and Australian spontaneous adverse event notifications
Author keywords

[No Author keywords available]
Indexed keywords

EID: 85044528094     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-1721     Document Type: Letter
Times cited : (81)
References (5)
  • 1
    • 85020403719 scopus 로고    scopus 로고
    • Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor
    • Fralick M, Schneeweiss S, Patorno E. Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor. N Engl J Med 2017;376:2300-2302
    • (2017) N Engl J Med , vol.376 , pp. 2300-2302
    • Fralick, M.1    Schneeweiss, S.2    Patorno, E.3
  • 2
    • 84962439093 scopus 로고    scopus 로고
    • Euglycemic diabetic ketoacidosis: A predictable, detectable, and preventable safety concern with SGLT2 inhibitors
    • Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: A predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care 2015;38:1638-1642
    • (2015) Diabetes Care , vol.38 , pp. 1638-1642
    • Rosenstock, J.1    Ferrannini, E.2
  • 3
    • 85007514629 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis
    • Handelsman Y, Henry RR, Bloomgarden ZT, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis. Endocr Pract 2016;22:753-762
    • (2016) Endocr Pract , vol.22 , pp. 753-762
    • Handelsman, Y.1    Henry, R.R.2    Bloomgarden, Z.T.3
  • 4
    • 85020116499 scopus 로고    scopus 로고
    • Euglycaemic diabetic ketoacidosis in patients using sodiumglucose co-transporter 2 inhibitors
    • Isaacs M, Tonks KT, Greenfield JR. Euglycaemic diabetic ketoacidosis in patients using sodiumglucose co-transporter 2 inhibitors. Intern Med J 2017;47:701-704
    • (2017) Intern Med J , vol.47 , pp. 701-704
    • Isaacs, M.1    Tonks, K.T.2    Greenfield, J.R.3
  • 5
    • 33646744337 scopus 로고    scopus 로고
    • Under-reporting of adverse drug reactions: A systematic review
    • Hazell L, Shakir SA. Under-reporting of adverse drug reactions: A systematic review. Drug Saf 2006;29:385-396
    • (2006) Drug Saf , vol.29 , pp. 385-396
    • Hazell, L.1    Shakir, S.A.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.